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Summary
 
The role of the spleen and of other organized secondary lymphoid organs for the induction of
protective antiviral immune responses was evaluated in orphan homeobox gene 11 knockout
mice (Hox11
 
 
 
/
 
 
 
) lacking the spleen, and in homozygous alymphoplastic mutant mice (aly/aly)
possessing a structurally altered spleen but lacking lymph nodes and Peyer’s patches. Absence of
the spleen had no major effects on the immune response, other than delaying the antibody re-
sponse by 1–2 d. In aly/aly mice, the thymus-independent IgM response against vesicular sto-
matitis virus (VSV) was delayed and reduced, whereas the T-dependent switch to the protec-
tive IgG was absent. Therefore, aly/aly mice were highly susceptible to VSV infection. Since
aly/aly spleen cells yielded neutralizing IgM and IgG after adoptive transfer into recipients with
normally structured secondary lymphoid organs, these data suggest that the structural defect
was mainly responsible for inefficient T–B cooperation. Although aly/aly mice generated de-
tectable, but reduced, CTL responses after infection with vaccinia virus (VV) and lymphocytic
choriomeningitis virus (LCMV), the elimination of these viruses was either delayed (VV) or
virtually impossible (LCMV); irrespective of the dose or the route of infection, aly/aly mice
developed life-long LCMV persistence. These results document the critical role of organized
secondary lymphoid organs in the induction of naive T and B cells. These structures also pro-
vide the basis for cooperative interactions between antigen-presenting cells, T cells, and B cells,
which are a prerequisite for recovery from primary virus infections via skin or via blood.
 
T
 
he immune system is functionally compartmentalized
into primary lymphoid organs responsible for the gen-
eration and differentiation of mature naive T and B cells
and into secondary lymphoid organs where immune re-
sponses are initiated. Only after activation do T and B cells
emigrate from secondary lymphoid organs to seek antigen
in the periphery (1–3). Secondary lymphoid organs include
the spleen, LN, and organized lymphoid tissues associated
with mucosal membranes such as the tonsils, the appendix,
and the Peyer’s patches (PP)
 
1
 
. These highly organized sec-
ondary lymphoid organs provide the structures where anti-
gen is efficiently retained and presented and where ordered
cellular interactions between APCs, T cells, and B cells
take place to initiate and promote efficient immune re-
sponses (1). Although it has been postulated that T or B
cells get anergized during possible initial peripheral en-
counter with antigen (4, 5), there is good experimental ev-
idence indicating that antigen encounter by naive T cells
does not occur, in general, outside of organized lymphoid
tissues and does not lead to activation (1–3, 6–9).
Classical experiments using isolated skin flaps connected
to the host via blood vessels with or without afferent lym-
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phatic vessels showed that antigen applied to the skin flap
induced a specific immune response only when both the
afferent lymphatic vessel and the draining LN were intact
(7, 10). These studies document, in our modern under-
standing, that emigrating APCs, in particular, dendritic cells
(DC) reaching local LN, are essential for the induction of a
specific immune response (11).
The role of the spleen in immune responses has been
studied in splenectomized patients and mice. The function
of the spleen is mainly to filter particulate and soluble anti-
gens from the blood (1, 12). Absence of the spleen caused
an increased susceptibility to generalized infections with
encapsulated bacteria (13–15) because the thymus indepen-
dent type 2 (TI-2) Ab response to polysaccharide compo-
nents of bacterial cell walls was markedly reduced (16–18).
Recently, two mouse strains with interesting changes of
secondary lymphoid organs have been developed or dis-
covered. First, a mutant mouse lacking a functional form of
the orphan homeobox gene 11 (
 
Hox11
 
) has been generated
by gene targeting. 
 
Hox11
 
 
 
/
 
 
 
 knockout mice (Hox11
 
 
 
/
 
 
 
)
lack the spleen, but otherwise appear normal. In particular,
no defects in other secondary lymphoid organs, in the thy-
mus, or the bone marrow have been detected (19). Second,
a mouse strain with a spontaneous autosomal recessive sin-
gle gene mutation, termed alymphoplasia (
 
aly
 
) has been de-
scribed. The homozygous aly/aly mutant mice lack all sec-
ondary lymphoid organs (especially LN and PP) except the
spleen, which, however, exhibited a disturbed structure. The
bone marrrow appeared to be normal, whereas the mor-
phological distinction between thymic cortex and medulla
was unclear (20, 21). These mutant mice that lack either
the spleen but not other secondary lymphoid organs, or
lack LN, PP etc. but not the spleen, now offer a new and
unique possibility to assess the role of these secondary lym-
phoid organs in the induction and maintenance of immune
responses, particularly against viral infections.
Our study revealed that absence of the spleen had only
minimal effects on antiviral immune responses, whereas
absence of LN and other organized secondary lymphoid
tissues caused a drastic change in the kinetics of virus repli-
cation and distribution relative to the kinetics of the pro-
tective immune response, particularly against the noncyto-
pathic lymphocytic choriomeningitis virus (LCMV). Lack
of LN led to overwhelming viral spread in vivo and, as a
consequence, to specific T cell exhaustion and virus persis-
tence.
 
Materials and Methods
 
Mice and Animal Experiments.
 
aly/aly mutant mice lacking LN
and PP were purchased from CLEA Inc. (Tokyo, Japan) and bred
locally under specific pathogen-free conditions by mating het-
erozygous (aly/
 
 
 
) females and homozygous (aly/aly) males. aly/
aly mutant mice were distinguished from aly/
 
 
 
 littermates by a
virtual absence of IgA in their sera measured with an anti-IgA
ELISA as described (20). Heterozygous littermates, which are
known to be fully immunocompetent (20), or C57BL/6 (B6) mice
and/or 129Sv(ev) were used as controls. In all experiments pre-
sented in this study, no significant differences between these dif-
ferent mouse strains used as normal controls were detected; there-
fore, data from one control strain (usually B6) are presented.
Hox11
 
 
 
/
 
 
 
 mice were generated by gene targeting on a 129Sv
background and bred locally under specific pathogen-free condi-
tions. Both mutant mice have been described in detail (19, 20).
B6 and 129Sv were purchased from the breeding colony of the
Institut für Labortierkunde (University of Zürich, Zürich, Swit-
zerland). All animal experiments were performed with age- and
sex-matched mice of 8–12 wk of age with permission of the vet-
erinary office according to cantonal and federal law requiring the
use of minimal numbers of animals.
 
Viruses.
 
The LCMV isolate WE (LCMV-WE) was originally
provided by Dr. F. Lehmann-Grube (Heinrich Herre Institute,
Hamburg, Germany) and the LCMV isolate Armstrong (LCMV-
Arm) by Dr. M.B.A. Oldstone (Scripps Clinic, La Jolla, CA).
LCMV-WE was grown on L929 cells and LCMV-Arm on BHK-
21 cells with a low multiplicity of infection (MOI). Vesicular sto-
matitis virus, serotype Indiana (VSV IND; Mudd-Summers iso-
late), originally obtained from Dr. D. Kolakofsky (University of
Geneva, Geneva, Switzerland) was grown on BHK-21 cells infected
at low multiplicity and plaqued on Vero cells (22). Vaccinia virus
(VV, strain Lancy) was obtained from the Schweizerisches Serum
und Impfinstitut (Bern, Switzerland). VV (strain WR) and re-
combinant VV expressing the glycoprotein of VSV IND (Vacc-
IND
 
G
 
) were generous gifts of Dr. B. Moss (Laboratory of Viral
Diseases, National Institute of Health, Bethesda, MD). (23). These
viruses were both grown at a low MOI and plaqued on BSC 40
cells. The recombinant baculovirus expressing the glycoprotein of
VSV IND (IND-G) was a gift of Dr. D.H.L. Bishop (Institute of
Virology, Oxford, U.K.). The recombinant baculovirus was de-
rived from nuclear polyhedrosis virus and was grown at 28
 
 
 
C in
 
Spodoptera frugiperda
 
 cells in spinner cultures using TC-100 me-
dium. Recombinant protein was produced as described (23).
 
Virus Titration.
 
LCMV titers of blood, centrifuged tissue ho-
mogenates, and virus stock solutions were determined with an
immunological focus assay as described (24). VV was quantified
by growing dilutions of tissue homogenates for 24–36 h on con-
fluent monolayers of BSC 40 cells. Plaques were visualized by
staining with crystal violet. All virus titers were expressed as log
 
10
 
(PFU of virus per organ or per gram organ) or as log
 
10
 
 (PFU of
virus per milliliter blood). The detection limits of the assays are
indicated in the figures.
Statistical comparisons were made using the two-tailed un-
paired Student’s 
 
t
 
 test. A 
 
P
 
 value of 
 
 
 
0.01 was regarded as signif-
icant.
 
Immunohistology.
 
Freshly removed organs were immersed in
Hank’s balanced salt solution and snap frozen in liquid nitrogen.
Tissue sections of 5-
 
 
 
m thickness were cut in a cryostat, placed on
siliconized glass slides, air dried, fixed with acetone for 10 min,
and stored at 
 
 
 
70
 
 
 
C. Secondary affinity-purified polyclonal anti-Ig
antisera were diluted in Tris-buffered saline (TBS; pH 7.4) con-
taining 5% normal mouse serum. All other dilutions were made in
TBS alone. Incubations were done at room temperature for 30
min; TBS was used for all washing steps. Alkaline phosphatase
was visualized using naphthol AS-BI phosphate and new fuchsin
as substrate. Endogenous alkaline phosphatase was blocked by le-
vamisole. All color reactions were performed at room temperature
for 15 min with reagents from Sigma Chemical Co. (St. Louis,
MO). Sections were counterstained with hemalum. Coverslips
were mounted with glycerol and gelatin.
For staining for LCMV and cell differentiation markers, rehy-
drated tissue sections were incubated with the following rat pri- 
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mary mAbs: anti–MHC class I (anti–H-2K
 
bdk
 
; M1/42; TIB-126;
American Type Culture Collection, Rockville, MD), anti–MHC
class II (anti-Ia
 
bdq
 
; M5/114; TIB-120; American Type Culture
Collection), anti-CD4 (YTS 191; reference 25), anti-CD8 (YTS
169; reference 25), anti-CD45R/B220 (RA3-6B2; PharMingen,
San Diego, CA), anti-LCMV (VL-4; reference 26), anti–red pulp
macrophages (RPM; F4/80; HB-198; American Type Culture Col-
lection), anti–marginal metallophils (MM; MOMA-1; Biomedi-
cals, Augst, Switzerland), anti–marginal zone macrophages (MZM;
ERTR-9; reference 27), anti–follicular dendritic cells (FDC; 4C11;
reference 28), anti–mucosal addressin cell adhesion molecule
1 (MAdCAM-1; MECA-367; PharMingen), anti–interdigitating
dendritic cells (IDC; NLDC-145; Biomedicals). Primary rat mAb
were revealed by a twofold sequential incubation with rabbit anti–
rat Ig and rat alkaline phosphatase anti–alkaline phosphatase com-
plex (DAKO, Glostrup, Denmark). CD11c on dendritic cells was
stained with the hamster mAb N418 (HB-224; American Type
Culture Collection). Primary hamster Ig were detected by alka-
line phosphatase–labeled rabbit anti–hamster Ig followed by alka-
line phosphatase labeled goat anti–rabbit Ig. Germinal centers (GC)
were stained with peanut agglutinin (12). To stain for Ig, sections
were incubated with biotinylated monoclonal rat anti–mouse IgM
(R6-60.2) or rat anti–mouse IgD
 
b
 
 (217-170) (PharMingen), fol-
lowed by alkaline phosphatase–labeled avidin–biotin complexes
(DAKO).
 
Detection of Virus-specific Cytotoxic T Cells In Vitro.
 
CTL activ-
ity of spleen or LN cells was determined by a 
 
51
 
Cr–release assay as
described previously (29). In brief, mice were infected with VV,
VSV, or LCMV at the indicated doses. 6 d (VV, VSV) or 8 d
(LCMV) later, spleen or LN cells were suspended at 9 
 
 
 
 10
 
6
 
/ml
in MEM supplemented with 2% FCS. MC57G (H-2
 
b
 
) fibroblast
target cells were infected with LCMV (MOI 
 
 
 
 0.01) 48 h, or with
VV (MOI 
 
 
 
 5) 3 h, or with VSV (MOI 
 
 
 
 15) 3 h before they
were used. Target cells were labeled with 0.4 mCi of [
 
51
 
Cr]so-
dium chromate for 2 h at 37
 
 
 
C and suspended at 10
 
5
 
/ml. Three-
fold dilutions of spleen or LN cells (100 
 
 
 
l) were incubated with
100 
 
 
 
l of targets for 5 h (LCMV, VSV) or 6 h (VV) in 96-well
round-bottom plates. 70 
 
 
 
l of supernatant was assayed for re-
leased 
 
51
 
Cr. The percent specific 
 
51
 
Cr-release was calculated as:
[(experimental release 
 
 
 
 spontaneous release) 
 
 
 
 100/(total re-
lease 
 
 
 
 spontaneous release)].
Alternatively, spleen cells were restimulated in vitro before
testing; 4 
 
 
 
 10
 
6
 
 spleen cells from infected mice were cultivated in
the presence of 2 
 
 
 
 10
 
6
 
 irradiated (25 gray) B6 stimulator spleen
cells in 2 ml of IMDM supplemented with 10% FCS, 10
 
 
 
5
 
2-mercaptoethanol and 5% Con A supernatant as a source of in-
terleukin-2 in 24-well plates. Stimulators were infected with
LCMV (MOI 
 
 
 
 0.1) or UV-inactivated VSV (MOI 
 
 
 
 15) for 2 h
at 37
 
 
 
C. 5 d later, restimulated spleen cells of one culture well
were resuspended in 1 ml of MEM supplemented with 2% FCS
and serial threefold dilutions of effectors were prepared (referred
to as dilution of standard culture) and tested as described above.
 
Serum Neutralization Test.
 
Neutralizing titers of sera were de-
termined as described (30). In brief, sera were prediluted 40-fold
in supplemented MEM and then heat-inactivated for 30 min at
56
 
 
 
C. Serial twofold dilutions were mixed with equal volumes of
virus diluted to contain 500 PFU/ml. After incubation for 90 min
at 37
 
 
 
C in an atmosphere containing 5% CO
 
2
 
, 100 
 
 
 
l of the se-
rum–virus mixture was transferred onto Vero cell monolayers in
96-well plates and incubated for 1 h at 37
 
 
 
C. The monolayers
were then overlaid with 100 
 
 
 
l DMEM containing 1% methyl
cellulose. After incubation for 24 h at 37
 
 
 
C, the overlay was re-
moved and the monolayer was fixed and stained with 0.5% crystal
violet. The highest dilution of the serum that reduced the num-
ber of plaques by 50% was taken as the neutralizing titer. To de-
termine IgG titers, undiluted serum was first pretreated with an
equal volume of 0.1 M 2-mercaptoethanol in saline. Titers repre-
sent log
 
2
 
 steps of 40-fold prediluted sera.
 
Assessment of Footpad Swelling.
 
Mice were inoculated with the
indicated LCMV doses in 30 
 
 
 
l MEM in both hind footpads, and
footpad swelling was assessed daily with a spring-loaded caliper (31).
 
In Vivo Depletion of CD4
 
 
 
 T Cells and Splenectomy.
 
T helper cells
were depleted as described (25). Efficiency of depletion was veri-
fied by FACS
 

 
 (Becton Dickinson, Mountain View, CA) analysis
of blood at the day of immunization, and again 8–12 d later. After
anesthesia of the mice, the spleen was prepared and two ligatures
were set with unresorbable silk (USP 4-0; B. Braun, SSC AG,
Emmenbrücke, Switzerland) before removal of the spleen. The peri-
toneal cavity was closed with a silk suture and the skin was stapled.
 
Adoptive Transfer Experiments.
 
Recipient mice were sublethally
irradiated with 5.0 gray 1 d before indicated numbers of spleen
cells were transferred adoptively. Immunization with 2 
 
 
 
 10
 
6
 
PFU live VSV IND or VaccIND
 
G
 
 was performed 1–3 d after
transfer (see Fig. 8). For the detection of LCMV-specific effector
functions, 5 
 
 
 
 10
 
7
 
 spleen cells of unprimed or of day-8 LCMV-
WE immunized mice (200 PFU LCMV-WE intravenously) were
adoptively transferred into aly/aly or aly/
 
 
 
 recipients which had
been infected with 2 
 
 
 
 10
 
5
 
 LCMV-WE inoculated into the foot-
pads 3 h before transfer. Thereafter, the resulting footpad swelling
reaction was monitored as described.
 
Flow Cytometry.
 
50 
 
 
 
l of blood was prepared in PBS contain-
ing 2% FCS, 0.2% NaN
 
3
 
, and 10 mmol EDTA. Cell surface
markers were quantified by staining with mAb conjugated with
fluorochromes. The following Abs were used: anti-CD4 PE (clone
H129.19), anti-CD8 FITC (clone 53-6.7) from GIBCO BRL (Ux-
bridge, U.K.), anti-CD45R/B220 PE (clone RA3-6B2) from
Sigma Chemical Co. Multiparameter analysis was performed with a
FACScan
 

 
 using logarithmic scales. Viable cells were gated by
forward and side scatter of light.
 
Results
 
Immunohistochemistry of aly/aly and aly/
 
 
 
 Spleen
 
The histological structures of the spleen of unimmunized
aly/aly mice and of heterozygous littermates were evaluated
with different mAb by immunohistochemistry (Fig. 1). The
absence of the distinct follicular structure of the white pulp
with an ill-defined boundary between white and red pulp
was obvious at low magnifications. This is clearly demonstrated
by the stainings for B cells (B220, IgM, IgD) and for certain
macrophage populations such as RPM, MM, or MZM.
The T cell areas stained with anti-CD4 or anti-CD8
mAbs seemed to be largely intact in the spleen of aly/aly
mice. The total number of CD4
 
 
 
 and CD8
 
 
 
 T cells and
their ratios were normal in spleen and peripheral blood
(FACS
 

 
 analyses not shown). In addition, the expression of
class I and II MHC molecules did not markedly differ. IDC
and DC seemed to be present in aly/aly mice in numbers
and distribution that were comparable to that of their het-
erozygous littermates. In contrast, numbers of B cells were
about threefold reduced in spleen and peripheral blood
(FACS
 

 
 analyses not shown) of aly/aly mice, and no pri-
mary or secondary follicles or GC were detectable in the 
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spleen, as previously reported (32). The lack of GC was ac-
companied by a complete lack of FDC. MM and MZM
were absent in aly/aly mice. In addition, MAdCAM-1, an
adhesion molecule normally expressed in the splenic mar-
ginal zone (MZ) (33), was undetectable in aly/aly spleens
(34). These data confirm and extend findings from Koike et
al. that showed the lack of the MZ in the spleen of aly/aly
mice (34). In summary, aly/aly mice showed, besides the
total lack of LN and PP, a prominent structural and cellular
defect of the splenic MZ accompanied by a reduction of B
cells and an absence of primary and secondary B cell folli-
cles together with a lack of differentiated FDC and of GC.
 
LCMV-specific CTL Responses, Immunopathological 
Footpad Swelling Reaction, and Perforin-dependent Virus 
Clearance in aly/aly and Hox11 /  Mice
To assess CD8  T cells and perforin-dependent antiviral
immune responses against a noncytopathic virus, mice were
immunized with 200 PFU LCMV (WE or Armstrong iso-
late) intravenously or subcutaneously into the hind foot-
pads, and 8 or 9 d later, spleen and/or LN cells were di-
rectly tested in a 51Cr–release assay. The two LCMV strains
differ in their tissue tropism and replication kinetics (35).
Control B6 and Hox11 /  mice yielded high LCMV-spe-
cific CTL responses 8 d after infection, whereas aly/aly
mice showed no detectable LCMV-specific CTL activity
(Fig. 2 A).
To evaluate the kinetics of LCMV-specific CTL re-
sponses in aly/aly mice with a very sensitive assay, spleen
cells were restimulated at different time points after LCMV
infection (day 5, 8, 20, and 70) for 5 d in vitro with
LCMV-infected, irradiated spleen cells (Fig. 2 B). The
LCMV-specific CTL activity of aly/aly mice on day 5 after
infection was identical to control mice, demonstrating the
induction of virus-specific CTLs in aly/aly mice. However,
already on day 8 after infection, the CTL activity of aly/aly
mice was  10-fold reduced compared to heterozygous lit-
termates. By day 20, virtually no LCMV-specific CTLs
were detectable in aly/aly mice. The mice did not recover
from this state of unresponsiveness until day 70.
Figure 1. Immunohistochemical analysis of aly/aly and aly/  spleens. Spleen sections of unimmunized (exception: LCMV staining) aly/aly and aly/ 
mice were stained with Abs of the indicated specificity. MM, MOMA-1; MZM, ERTR-9; MAdCAM-1 on endothelial cells of the marginal sinus,
MECA-367; RPM, F4/80; FDC, 4C11; GC, PNA; IgM, surface IgM  B cells, R6-60.2; IgD, surface IgD  B cells, 217-170; B220, CD45R  B cells,
RA3-6B2; CD4, CD4  T cells, YTS-191; CD8, CD8  T cells, YTS-169; MHC I, H-2Kbdk, M1/42; MHC II, Iabdq on macrophages, DC, and B cells,
M5/114; IDC, NLDC-145; DC, CD11c on dendritic cells N418; LCMV, LCMV-infected cells 8 d after infection with 200 PFU LCMV-WE intrave-
nously, VL-4. Original magnification: 100-fold for all panels.
Figure 2. CTL response, footpad swelling reaction, and blood virus ti-
ter after LCMV infection of aly/aly and Hox11 /  mice. Mice were im-
munized with 200 PFU LCMV-WE intravenously (A, left, B and D),
LCMV-Arm intravenously (A, right), or 100 PFU LCMV-WE into both
hind footpads (i.fp., A, middle, and C). After 8 d, spleens were removed
and single cell suspensions were tested directly ex vivo in a conventional
51Cr–release assay (primary [1 ] CTL ex vivo) with LCMV-infected (open
symbols) or untreated (closed symbols) MC57G as target cells.    , aly/aly
spleen cells;    , Hox11 /  LN cells;    , spleen cells of control B6
mice;    , LN cells of control B6. Each line represents an individual
mouse with the exception of the B6 mice in A, middle and right (squares
and circles) representing the mean of three mice. (B) spleens were removed
at the indicated time points after infection with 200 PFU LCMV-WE in-
travenously and restimulated in vitro for 5 d (secondary [2 ] CTL after in
vitro restimulation) with irradiated LCMV-infected spleen cells. Cultures
were then tested on LCMV-infected (open symbols) or untreated (closed
symbols) MC57G cells radioactively labeled with 51Cr.    , aly/aly mice;
   , aly/  control mice. Each line represents one individual mouse. (C)
mice were infected with 100 PFU LCMV-WE into both hind footpads.
The footpad thickness was measured daily with a spring-loaded caliper.
 , aly/aly mice;  , Hox11 /  mice;  , B6 controls. Each line represents
the mean of both hind footpads of three mice. Error bars indicate the SD
within the experimental group. Results of one (out of three) similar ex-
periment are shown. (D) Mice were infected with 200 PFU LCMV-WE
intravenously. Blood was taken at the indicated time points and virus ti-
ters were determined as described (24). LCMV titers are given as log10
(virus titer/ml blood).  , aly/aly mice;  , Hox11 /  mice;  , control
B6 mice. Each line represents one mouse. Data of 4 mice/group are
shown. The detection limit of the assay is indicated (det. lim.). One out of
two similar experiments is shown.2162 Lymphoid Organ Defects Lead to Impaired Antiviral Immune Responses
To assess the in vivo consequences of the in vitro–mea-
sured CTL activities, the CD8  T cell–dependent immu-
nopathological footpad swelling reaction was measured
daily after local infection with 100 PFU LCMV-WE into
both hind footpads (Fig. 2 C). Control and Hox11 /  mice
exhibited a similar CD8  T cell–mediated swelling reac-
tion from day 6 until day 10. The swelling reaction was
prolonged in Hox11 /  mice, possibly reflecting a more
pronounced CD4  T cell response (31). In contrast, aly/aly
mice showed no footpad swelling reaction. After intracere-
bral (i.c.) infection with 3, 30, or 300 PFU of the neuro-
tropic LCMV-Arm, aly/aly mice did not succumb to the
usually observed lethal immunopathological choriomenigi-
tis mediated by CD8  CTLs; nine of nine aly/aly mice
(three mice per virus dose) survived for  30 d without
clearance of the virus, whereas nine of nine control B6 and
six of six Hox11 /  mice died between 7–9 d after infec-
tion.
To evaluate the kinetics of virus clearance in vivo, the
elimination of LCMV after peripheral infection was moni-
tored. As shown in Fig. 2 D, aly/aly mutant mice were not
able to clear the virus from their blood or any other organ
tested (spleen, see Fig. 1, LCMV staining). Virus persisted
for life after infection with any of the tested doses (3–
10,000 PFU) or routes of infection (intravenous, intraperi-
toneal, intracerebral, or subcutaneous) of both LCMV strains
(WE or Arm) used in this study. It has been shown that
 106 PFU of intravenous LCMV-WE are needed to pro-
voke CTL exhaustion and virus persistence in adult immu-
nocompetent B6 mice (36). Thus, aly/aly mice were at
least 106-fold more susceptible to become LCMV carriers than
normal B6 mice. In contrast to aly/aly mutant mice, blood
virus titers of control and Hox11 /  mice reached barely
detectable levels (Fig. 2 D); the latter mice cleared LCMV
from the tested organs at the latest by day 15 (not shown).
Careful analysis of LCMV titers in different organs of
aly/aly and aly/  mice during the first 4 d after intrave-
nous infection revealed that virus titers of the spleen were
Table 1. LCMV Titers of aly/aly and aly/  Mice Early after Infection with 104 PFU LCMV-WE Intravenously
Time after
infection
Spleen Liver Lung
aly/aly aly/  aly/aly aly/  aly/aly aly/ 
h
12  DL*‡ 3.7   0.6* 3.2   0.2 3.3   0.5  DL  DL
24 3.7   0.7* 6.6   0.1* 3.5   0.4 3.9   0.4  DL  DL
48 6.0   0.3* 7.8   0.2* 4.3   0.3 3.4   0.7 4.3   0.3* 3.3   0.2*
96 6.6   0.1 6.4   0.1 5.4   0.3* 4.6   0.3* 5.6   0.2* 4.6   0.3*
Mice were infected with 104 PFU LCMV-WE intravenously. At the indicated time points after infection mice were killed and virus titers were de-
termined in different organs. Values are given as log10(PFU LCMV/g organ)   SD of 3–4 mice/experimental group.
*P  0.01, significant difference of LCMV titers between aly/aly and aly/  mice (Student’s t test).
‡DL, detection limit of the assay (spleen, 2.0; liver, 3.0; lung, 2.5).
Representative data of one out of three comparable experiments are shown.
 100 times lower in aly/aly mice, 12, 24, and 48 h after in-
fection, whereas in peripheral solid organs (liver and lung)
the titers were generally higher (Table 1). This suggests that
LCMV particles were less efficiently removed from the
blood by the spleen of aly/aly mice. Therefore, probably
more infectious viral particles reached peripheral solid organs.
To test whether only the induction of LCMV-specific
CTL responses was less efficient or whether effector func-
tions of primed CD8  T cells were affected by the struc-
tural defect of aly/aly mice also, the following adoptive
transfer experiments were performed. Naive aly/aly or aly/ 
recipient mice were infected with 2   105 LCMV-WE
into the footpads. 3 h later, 5   107 spleen cells of either
naive or day-8 LCMV-primed B6 mice (200 PFU LCMV-
WE intravenous) were adoptively transferred. Thereafter,
the immunopathological footpad swelling reaction was
monitored. aly/aly and aly/  recipients of LCMV-primed
spleen cells showed a similar early swelling peak already
18–24 h after transfer, reflecting the local LCMV-specific
effector phase of the transferred LCMV-primed cells. In
contrast, recipients of naive spleen cells showed no early
swelling reaction. The usual primary footpad swelling reac-
tion peaking around day 8 after LCMV infection was only
detectable in aly/  recipients of naive spleen cells (Fig. 3
A). aly/aly recipients of naive B6 spleen cells did not
mount a detectable swelling reaction. On day 9 after infec-
tion, LCMV titers in different organs and the CTL re-
sponse of 5 d in vitro restimulated splenocytes was mea-
sured. aly/  recipients of naive and primed spleen cells
showed a potent CTL response and complete clearance of
the virus from the tested organs. In contrast, aly/aly recipi-
ents exhibited clear differences in virus titers and CTL ac-
tivity dependent upon whether the transferred cells were
primed or naive. Viral titers were about 100 times lower
and the CTL activity 10–30-fold higher in the aly/aly re-
cipients of primed spleen cells, demonstrating that the ef-
fector function of the transferred primed T cells was unim-
paired in aly/aly mice. (Fig. 3, B and C).2163 Karrer et al.
VV-specific CTL Responses and Virus Elimination Kinetics 
of aly/aly and Hox11 /  Mice
To test the CTL response of these mutant mice against a
cytopathic virus, mice were immunized with 2   106 PFU
vaccinia virus (VV) strain WR or Lancy. 6 d later, spleens
and/or LN were removed and tested directly in a VV-spe-
cific  51Cr–release assay with VV-infected MC57G fibro-
blasts as target cells. LN cells of Hox11 /  mice exhibited
comparable CTL activity to LN cells of B6 and 129Sv con-
trols (Fig. 4 A).
The VV-WR–specific CTL response of aly/aly mice was
only  3–10-fold reduced compared to control B6 mice
(Fig. 4 B). If mice were infected with VV-Lancy, an atten-
uated VV strain that does not measurably replicate in im-
munocompetent mice (37), the CTL response was reduced
by at least a factor of 30 (Fig. 4 C). The elimination of VV-
WR from the tested organs was clearly delayed in aly/aly
mice compared to Hox11 /  or control B6 mice (Fig. 4, D
and E).
Immune Responses against VSV
VSV-specific CTL Response. The dispensable but usu-
ally induced VSV-specific primary CTL response on day
6 after immunization with 2   106 live VSV IND of
Hox11 /  and control B6 mice was comparable (Fig. 5 A).
No primary ex vivo CTL activity could be detected in aly/
aly mice (Fig. 5 B). Upon in vitro restimulation for 5 d
with VSV-infected, irradiated spleen cells, VSV-specific CTLs
were also detectable in aly/aly mice, but still 10–30-fold re-
duced compared to B6 mice (Fig. 5 C).
VSV-specific Neutralizing Ab Response. The VSV-neu-
tralizing Ab response of aly/aly, Hox11 / , and control
mice was assessed using different antigenic preparations de-
rived from VSV IND, e.g., live and UV-inactivated VSV
IND particles, a recombinant VV expressing the glycopro-
Figure 4. VV-specific CTL response and VV clearance. Mice were in-
fected with 2   106 VV-WR (A, B, D, and E) or VV-Lancy (C). On day
6, spleens and/or LN were removed and directly tested in a standard
51Cr–release assay (A–C). (Open symbols) VV-infected 51Cr-labeled
MC57G cells (A–C) as target cells. (Closed symbols) Uninfected target
cells.    , aly/aly spleen cells;    , Hox11 /  LN cells;    , control
B6 spleen cells;    , control B6 LN cells. Each line represents one indi-
vidual mouse with the exception of the controls in A (squares and circles)
where the mean of three mice is shown. D and E show VV titer in ovary
and lung given as log10(PFU per organ) at different time points after infec-
tion with 2   106 PFU VV-WR intravenously. Each line represents the
mean and the SD of three mice per group. The detection limit of the as-
say (det. lim.) is indicated.  , aly/aly mice;  , Hox11 /  mice;  , B6
control mice. Data of one of two comparable experiments is shown.
Figure 3. LCMV-specific immune response of aly/aly mice after adop-
tive transfer (AT) of naive or LCMV-primed B6 spleen cells. Recipient
mice were infected with 2   105 LCMV-WE into the footpads. 3 h later,
5   107 naive or day 8 LCMV-WE–primed B6 spleen cells were adop-
tively transferred.  , aly/aly recipients, adoptively transfused with naive
B6 spleen cells;  , aly/aly recipients transfused with day-8 LCMV-
primed B6 spleen cells;   aly/  recipients transfused with day-8 LCMV-
primed B6 spleen cells;   aly/  recipients transfused with naive B6 spleen
cells. The footpad swelling reaction was monitored daily (A). Means and
SD are given for both hind footpads of two to three mice per group in a
0.1-mm scale. The CTL response was measured on day 9 after infection
(B). The spleen cells were restimulated with irradiated LCMV-infected spleen
cells for 5 d. Cultures were then tested on LCMV-infected 51Cr-labeled
MC57G cells. Unspecific lysis of uninfected targets was  10%. Each line
represents the mean of two to three mice. LCMV titers in spleen and liver
on day 9 after infection (C). Single values of individual mice, means (hori-
zontal bars) and the detection limit (det. lim.) of the assay are indicated.
Values are given as log10(PFU per organ). The data represent one out of
two comparable experiments.2164 Lymphoid Organ Defects Lead to Impaired Antiviral Immune Responses
tein of VSV IND (VaccINDG), and IND-G produced and
extracted from a baculovirus expression system. Earlier
studies showed that the neutralizing IgM response to VSV
particles peaks around day 8 after immunization, is largely
T helper cell–independent, and reflects B cell responsive-
ness directly (38–40). Live and UV-inactivated VSV IND
particles have been defined to be TI-1 antigens without
stimulating B cells polyclonally, whereas VaccINDG and
IND-G were shown to be TI-2 antigens (40, 41). The
neutralizing IgG response peaks around day 12 and is T
helper cell–dependent.
Upon intravenous immunization with 2   106 live VSV
IND, aly/aly mice showed a delayed and overall reduced
production of neutralizing IgM. By day 8, they reached ti-
ters comparable to controls. Most importantly, aly/aly mice
failed to produce neutralizing IgG at any time point tested
(Fig. 6 A). The protection from lethal encephalitis caused
by VSV mostly depends on the production of neutralizing
IgG by day 6–8 (42). Therefore, all aly/aly mice died after
infection with live VSV IND between day 6 and day 10.
Spleenless Hox11 /  mice showed a delay in the IgM re-
sponse upon intravenous infection and, to a smaller degree,
in the production of IgG, but they were protected from
encephalitis.
After infection with 2   106 PFU of the TI-2 Ag Vacc-
INDG intravenously, aly/aly mice mounted a delayed and
reduced neutralizing IgM response, but completely failed
to switch to IgG. Hox11 /  mice again exhibited a delay
in the neutralizing IgM and IgG response (Fig. 6 B).
To examine the influence of the route of Ag administra-
tion on the neutralizing Ab response against VSV, we im-
munized aly/aly and Hox11 /  mice with 10  g of the
nonreplicating TI-2 Ag IND-G solubilized in balanced salt
solution intravenously or emulsified in IFA subcutaneously
(Fig. 6, C and D). Both immunization protocols failed to
induce detectable neutralizing IgM or IgG in aly/aly mice,
even after a booster injection. After hyperimmunization by
four injections of 10  g IND-G or 108 PFU UV-inacti-
vated VSV IND in IFA intraperitoneally in 10-d intervals,
a substantial neutralizing IgM titer, but no IgG, was in-
duced in aly/aly mice (not shown). Hox11 /  mice
promptly responded to IND-G by both routes after a single
immunization; a delay of 2–3 d in the IgM response was
noticed only after intravenous immunization.
Effects of Splenectomy or Depletion of CD4  T Cells of aly/aly, 
Hox11 / , and B6 Control Mice on the Neutralizing IgM 
Response after Immunization with VSV IND or VaccINDG
The role of secondary lymphoid organs in TI-1 B cell
responses was further assessed in mice lacking all secondary
lymphoid organs, i.e., splenectomized aly/aly mice. aly/aly
and control aly/  mice were splenectomized or sham op-
erated and 3 wk later they were immunized with 2   106
PFU live VSV IND intravenously. The IgM response was
completely absent in three out of four splenectomized aly/
aly mice. Only one mouse still produced a low neutralizing
IgM titer on day 8, whereas the IgM response of sham op-
erated aly/aly mice was similar to untreated ones. All aly/
aly mice, splenectomized or not, died from VSV-induced
encephalitis within 9 d. The IgM response of splenecto-
mized aly/  (or 129Sv, not shown) controls was very sim-
ilar to the response of Hox11 /  mice showing a delay af-
ter intravenous immunization compared to sham-operated
control mice (Fig. 7 A).
To further analyze whether the IgM response to the TI
B cell Ag VaccINDG or VSV IND was still independent of
T help in these mutant mice, aly/aly, Hox11 / , and con-
trol B6 mice were depleted of CD4  T cells before immu-
nization. The neutralizing IgM response after immuniza-
tion with the TI-2 Ag VaccINDG was T help dependent in
aly/aly mice, but it was largely T help independent in
Hox11 /  and in B6 controls (Fig. 7 B). This indicates that
a low level of cooperation between T and B cells still oc-
curs in aly/aly mice, which is sufficient to support the IgM
response to VaccINDG, but not sufficient to induce the
switch to IgG. As expected, aly/aly, Hox11 / , and B6
control mice treated identically with anti-CD4 and immu-
nized with the TI-1 Ag live VSV IND generated a T help
independent IgM response (data not shown).
Effect of Reciprocal Adoptive Transfer of Naive Spleen Cells 
Between aly/aly and Control Mice on the VSV-specific
Ab Response
To evaluate in vivo whether the defect of cognate inter-
action between B and T cells in aly/aly mice seen in the
previous experiments is mainly due to a cellular defect of
the B or T cell compartment, or of both together, or is due
to the structural defect of secondary lymphoid organs in
aly/aly mice, reciprocal adoptive transfer experiments be-
tween aly/aly and control mice were performed (Fig. 8).
Figure 5. VSV-specific CTL response. Mice were infected with 2  
106 live VSV IND intravenously. On day 6, spleens and LN were re-
moved and directly tested in a standard 51Cr–release assay (A and B). Al-
ternatively, spleen cells were restimulated in vitro for 5 d with VSV-infected
and irradiated spleen cells (C) before cultures were tested. (Open symbols)
VSV infected MC57G cells as target cells. (Closed symbols) Uninfected tar-
get cells.    , aly/aly spleen cells;    , Hox11 /  LN cells;    , con-
trol B6 spleen cells;    , control B6 LN cells. Each line represents one
individual mouse, with the exception of the controls in A (squares and cir-
cles) where the average of three mice is shown. Data of one out of three
representative experiments is shown.2165 Karrer et al.
On day  2 recipients were irradiated with 5.0 gray, on
day  1 indicated numbers of spleen cells were transferred,
and on day 0 mice were immunized with 2   106 PFU live
VSV IND or VaccINDG. 108 aly/aly spleen cells or a ti-
trated number of aly/  spleen cells (108, 3   107, or 107)
were transferred into irradiated B6 recipients (Fig. 8 A). Ir-
radiated B6 recipients without adoptive cell transfer did not
respond to both immunization protocols, demonstrating
the effectiveness of the irradiation. After transfer of graded
numbers of aly/  spleen cells, the recipients responded with
correspondingly graded neutralizing Ab responses; the mice
receiving the highest cell number responded the best. Re-
cipients of 108 aly/aly spleen cells exhibited a neutralizing
IgM and IgG response against VSV IND and VaccINDG
that was comparable to that of recipients transfused with
107   3   107 aly/  spleen cells. This result indicates that
aly/aly spleen cells exhibit the capacity to respond to thy-
mus-dependent and -independent Ag after transfer into a
recipient with an intact structure of secondary lymphoid
organs. After compensation for the threefold reduced num-
ber of B cells (FACS analysis not shown), the response
was almost comparable to recipients of aly/  spleen cells.
A second adoptive transfer experiment evaluated whether
naive spleen cells of B6 mice adoptively transferred into ir-
radiated aly/aly or aly/  recipients were able to respond to
immunization with VaccINDG (Fig. 8 B). The transfer of
Figure 6. VSV-neutralizing IgM and IgG responses. Mice were immunized with 2   106 PFU live VSV IND intravenously (A), 2   106 PFU Vacc-
INDG intravenously (B), or with 10  g IND-G in balanced salt solution intravenously (C), or emulsified in IFA and injected subcutaneously at the base
of tail (D). Blood was taken at the indicated time points and the neutralizing IgM (upper panels) or IgG titers (lower panels) were determined in the sera. Ti-
ters represent log2 dilutions of 40-fold prediluted sera.  , aly/aly mice;  , Hox11 /  mice;  , B6 control mice. Each line represents one individual
mouse. One out of three similar experiments is shown.2166 Lymphoid Organ Defects Lead to Impaired Antiviral Immune Responses
108 B6 spleen cells into aly/aly recipient mice failed to in-
crease the neutralizing IgM or IgG response compared to
untreated aly/aly mice. Irradiation prevented aly/aly and
aly/  mice from responding to VaccINDG. In control ex-
periments, 108 B6 spleen cells were transferred into aly/ 
recipients and neutralizing IgM and IgG were readily in-
duced.
These adoptive transfer experiments indicate that the T and
B cells of aly/aly mice can respond to viral antigens if trans-
ferred into normal mice possessing organized secondary lym-
phoid organs. In contrast, spleen cells of normal B6 mice
transferred into aly/aly mice did not function properly.
Discussion
In this study we investigated the effects of an altered
morphology of secondary lymphoid organs on antiviral im-
mune responses using Hox11 /  and aly/aly mutant mice.
Absence of the spleen in Hox11 /  mice resulted in a cer-
tain delay of the systemic Ab response without measurable
consequences for T cell–dependent immune functions. Ab-
sence of LN and PP, together with structural alterations of
the splenic white pulp, resulted in a complete shift of the
balance between virus replication and the host’s antiviral
immune defense, with, as a consequence, establishment of
persistent infection with a noncytopathic virus (LCMV)
and increased susceptibility to cytopathic viruses such as
VSV and VV.
The immunohistological analysis of aly/aly spleens shown
in this study confirms and extends previous reports on the
absence of MM and MZM and of FDC in aly/aly mice
(32, 34). The genetic defect leading to the aly/aly pheno-
type is not yet defined (43). Since mice deficient for lym-
photoxin   or for both lymphotoxin   and TNF-  also
lack LN and PP and show similar structural changes in the
splenic white pulp, there might be a common mechanism
during organogenesis, even though the genomic localiza-
tions of the affected genes are different (43–47).
Although LCMV infection led to the induction of virus-
specific CTLs in the spleen of aly/aly mice, virus replicated
throughout the whole body and life-long virus persistence
was established. The absence of organized secondary lym-
phoid organs led to rapid exhaustion of CTLs after infec-
tion with very low doses of a rather slow replicating strain
of LCMV, even if administered locally into the footpads.
Figure 7. VSV-neutralizing Ab response of aly/aly, Hox11 / , and B6
control mice after splenectomy and immunization with VSV IND (A) or
after depletion of CD4  T cells and immunization with VaccINDG (B).
(A) Mice were splenectomized or sham operated and 3 wk later they
were immunized with 2   106 PFU live VSV IND intravenously. Blood
was taken at the indicated time points and the neutralizing IgM titer was
determined. Each line represents the mean of four mice; error bars indi-
cate the SD.  , aly/aly mice, sham operated;  , splenectomized aly/aly
mice;  , splenectomized aly/  controls;  , aly/  controls, sham oper-
ated;  , Hox11 / , sham operated. Spl X, splenectomized; sh.op., sham
operated. Data from one of two independent experiments are shown. (B)
Mice were depleted of CD4  T cells and then immunized with 2   106
PFU VaccINDG intravenously. Blood was taken at the indicated time
points and the neutralizing IgM titer was determined. Efficiency of deple-
tion was confirmed by FACS analysis at the day of immunization and at
day 8. Each line represents the mean of three to four mice, error bars in-
dicate the SD.  , aly/aly mice, CD4 depleted;  , aly/aly mice, not de-
pleted;  , B6 controls, CD4 depleted;  , B6 controls, not depleted;  ,
Hox11 / , CD4 depleted;  , Hox11 / , not depleted.  CD4, depleted
of CD4  T cells; n.dp., not depleted. Data from one of three independent
experiments are shown.
Figure 8. VSV-neutralizing Ab responses of irradiated recipients after
AT of naive spleen cells. Recipients were irradiated with 5.0 gray on day
 2 and adoptively transfused with various numbers of spleen cells on day
 1 and then immunized with 2   106 PFU live VSV IND or VaccINDG
intravenously on day 0 and boosted on day 8 with the same antigen (8 A,
right). Blood was taken from the mice at the indicated time points after
priming or boosting and the neutralizing IgM (top) or IgG titers (bottom)
were measured. (A)  , AT of 108 aly/aly spleen cells into irradiated B6;
 , AT of 108, 3   107 or 107 aly/  spleen cells into irradiated B6;  , ir-
radiated B6 not receiving cells;  , untreated B6. no Spl, no spleen cells
transferred. (B)  , AT of 108 B6 spleen cells into irradiated aly/aly;  ,
untreated aly/aly;  , irradiated aly/aly not receiving cells;  , AT of 108
B6 spleen cells into irradiated aly/ ;  , untreated aly/  mice. no Spl, no
spleen cells transferred; irr., irradiated. Each line represents the mean of
four mice, variations of individual mice were below two 1:2 dilution
steps.2167 Karrer et al.
Previous experiments had shown that exhaustion by activa-
tion and deletion of LCMV-specific CTLs in adult immu-
nocompetent mice was only possible with high doses ( 106
PFU) of fast replicating LCMV strains after systemic intra-
venous infection (36). Exhaustion was not established after
subcutaneous infection apparently because staggered induc-
tion of LCMV-specific CTL precursors, first in the drain-
ing LN, and subsequently in other secondary lymphoid
organs, reduced their concerted end differentiation (48).
Absence of LN in aly/aly mice correlated with the dramat-
ically increased susceptibility to exhaustion after subcutane-
ous infection; due to this absence, the distribution of virus
and the kinetics of CTL activation and exhaustion were ap-
parently similar after local subcutaneous and systemic intra-
venous infection in aly/aly mice. Our results offer at least
two possible explanations for the tremendously increased
susceptibility to exhaustion of LCMV-specific CTLs in aly/
aly mice. Due to the poor organization of the white pulp
with the lack of the MZ Ag trapping and probably Ag pre-
sentation was less efficient in spleens of aly/aly mice due to
the lack of the MZ and due to the poor organization of the
splenic white pulp. This could first lead to a delay in CTL
induction. Second, the initial virus distribution was different
in aly/aly mice; less viral particles were retained in the
spleen and therefore more virus reached peripheral solid
organs where replication is probably less restricted (Table
1) and where induced CTL in addition may die because of
interleukin deprivation.
Although we were not able to demonstrate a less effi-
cient CTL induction early after LCMV infection (Fig. 2 B),
the 3–30-fold reduced VV- and VSV-specific CTL re-
sponses suggested that CTL induction was affected in these
mice. This impairment was modulated by the amount of
inflammation and bystander activation correlating with the
virulence of the infecting virus (49, 50).
aly/aly mice produce delayed and reduced T help–inde-
pendent neutralizing IgM against live VSV. Since early IgM
responses are usually associated with antigen in MM and
MZM (12, 26, 51, 52), this result probably also reflects the
insufficiency of aly/aly spleens to filter out antigen due to
the absence of an organized MZ. The defect of aly/aly
mice also prevented cooperative interactions of B and T
cells to induce isotype switch. Adoptive transfer experi-
ments indicated that the B and T cells of aly/aly mice were
able to cooperate and to mount an immune response upon
transfer into a recipient with a normal structure of second-
ary lymphoid organs. In contrast, transfer of spleen cells of
B6 origin into aly/aly recipients did not reconstitute the
immune response. These data are compatible with in vitro
findings showing normal activities of aly/aly spleen cells
when used in mitogen-induced in vitro proliferation of B
and T cells, and also in mixed lymphocyte reactions as re-
sponders and stimulators (20). We therefore conclude that
the defect of aly/aly mice relevant for the observed immu-
nodeficiency is mainly related to the impaired structure of
secondary lymphoid organs, i.e., the lack of LN and PP and
the described alterations of the spleen, and not due to a cel-
lular defect of the T and/or B cell compartment. However,
the minor effect shown in Fig. 8, where we had to transfer
 10 times more aly/aly than aly/  spleen cells to elicit the
same neutralizing IgM response, could correlate with a
possible impairment of B cells, as it has been suggested in a
recent report showing a defect of aly/aly B cells in class
switching and somatic hypermutation (32).
It is well established in humans and mice that the spleen
plays a major role in the protection against blood borne in-
fectious agents, particularly encapsulated bacteria (13–15).
Especially the TI-2 Ab response to polysaccharide compo-
nents of bacterial cell walls is known to be dependent on an
intact spleen. Splenectomized patients and mice have been
shown to respond very poorly to primary immunizations
with TI-2 antigens (16, 17). In earlier studies, mainly MZM
of the spleen were regarded as critical components in the
induction of TI-2 responses (53, 54). More recent data sug-
gested that FDC, rather than MZM, are the critical cells in
the initiation of TI-2 responses (55, 56). Since aly/aly mice
lack both MZM and FDC, it was not surprising that their
Ab response to the TI-2 antigens VaccINDG and IND-G
was severely reduced. CD4 depletion revealed that the IgM
response of aly/aly mice against VaccINDG was T help de-
pendent (Fig. 7 B). This finding, therefore, suggests that
T–B collaboration in the spleen of aly/aly mice is not suffi-
cient to induce class switch to IgG, but is sufficient to pro-
mote the TI-2 IgM response to VaccINDG.
It was surprising that Hox11 /  mice responded nearly
normally to the glycoprotein of VSV IND offered as a TI-2
antigen. The IgM response to intravenous immunization
with VaccINDG and IND-G was delayed by 1–2 d, but
was otherwise unaltered, even after CD4 depletion (Fig. 7
B). Apparently, the spleen is not critical for these responses
and/or Hox11 /  mice have developed compensational
mechanisms for their absent spleen during ontogeny and
the neonatal period. This is also suggested by a finding in
rats that only adult, but not neonatal, splenectomy resulted
in a depression of the Ab response to TI-2 antigens (57).
Thus, the importance of antigen migration to LN in the
induction of immune responses to model antigens or to
skin allografts is confirmed in this study for antiviral immu-
nity (7, 9, 10). The experiments here also show that effec-
tor cells, once they were induced, functioned in aly/aly
mice and that LN were not limiting for emigration and
function of activated effector T cells (Fig. 3). This result is
compatible with the classical experiments of Frey and Wenk
and those of Barker and Billingham, who showed that
primed, immune T cells were capable of inflaming or re-
jecting skin in the absence of afferent lymph vessel or LN
connection (7, 10).
Splenectomized aly/aly mice devoid of all organized sec-
ondary lymphoid organs did not respond to immunizations
with potent TI-1 B cell antigens. This finding comple-
ments those for T cells as just discussed and indicates that
induction of B cells must occur in organized secondary
lymphoid organs. Once B cells are induced, they can emi-
grate to the bone marrow and home as Ab-forming cells
(12, 58).
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efficient and balanced antiviral immune response is not
only dependent on mature B and T cells and APCs; with-
out critical interactions in the highly organized structure of
secondary lymphoid organs, T and B cells are not properly
induced. These results suggest that naive T cells do not
usually encounter antigen and cannot be induced in the pe-
riphery (a) because they cannot emigrate into solid tissue,
(b) because antigen transport via afferent lymph to orga-
nized secondary lymphoid organs is critical for the prompt
induction of an immune response, and (c) because only upon
specific activation can T cells emigrate to seek antigen in
the periphery. Therefore, the balance between kinetics and
distribution of antigen in the periphery versus antigen in
organized lymphoid organs seems to determine whether
antigen is ignored or induces or exhausts T cells.
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